Antibody-Based Therapeutics in Autoimmune Diseases: Mechanisms, Challenges, and Future Perspectives. [PDF]
Mahroum N.
europepmc +1 more source
BAFF and APRIL signaling in the B-cell lineage: implications for the pathogenesis of ANCA-associated vasculitis. [PDF]
Shimojima Y +5 more
europepmc +1 more source
Impact of Prior Exposure to Anisakis simplex Antigens on Immune Response During SARS-CoV-2 Vaccination. [PDF]
Cuéllar C +9 more
europepmc +1 more source
Plasma cells - a key target in antibody-mediated diseases. [PDF]
Fiebig L +9 more
europepmc +1 more source
Chimeric antigen receptor T-cell therapy in neuroimmune diseases: mechanistic rationale, clinical experience, and translational challenges. [PDF]
Yi Y +9 more
europepmc +1 more source
Chimeric antigen receptor T-cell therapy in systemic lupus erythematosus: From B cell depletion to immune reprogramming. [PDF]
Zhao W, Chen M, Long J, Lu P, Jin J.
europepmc +1 more source
Dual B -Cell Maturation Antigen/CD19 Chimeric Antigen Receptor- T Therapy for AL Amyloidosis : Targeting the Clone, Saving the Kidney. [PDF]
Sobczak K, Leick MB.
europepmc +1 more source
Mechanisms, optimization strategies, and salvage options for CAR-T cell therapy. [PDF]
Wu B +11 more
europepmc +1 more source
Bioengineering strategies for off-the-shelf, cell-based cancer immunotherapy. [PDF]
Barlow BR +3 more
europepmc +1 more source
B7 homolog 3-targeted CAR-T cells secreting EGFR T-cell engagers for improved control of glioblastoma progression. [PDF]
Zhang Z +9 more
europepmc +1 more source

